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Introduction
Next-generation sequencing has led to the discovery of a
number of disease-associated genes in patients with
uncharacterized autoinflammatory diseases and has
pointed to new pathways regulating immune function.
Objective
To investigate the pathogenesis of disease in patients
with the deficiency of the CCA-adding enzyme tRNA
nucleotidyltransferase 1 (TRNT1). The TRNT1 enzyme
catalyzes an essential step for tRNA maturation and
protein synthesis, however it is largely unknown how
abnormalities in this pathway lead to inflammation and
immunodeficiency.
Patients and Methods: Whole exome sequencing
(WES) was performed in a consanguineous Saudi family
with 2 affected siblings and in a parent-child trio; candi-
date gene screening was subsequently performed in 3
sporadic Caucasian patients. Cytokine profiling, tissue
immunohistochemistry, and deep RNA and tRNA
sequencing were performed in patients’ primary cells.
Protein function was studied in zebrafish embryos.
Results
We have identified 7 patients with biallelic homozygous or
compound heterozygous mutations in the TRNT1 gene.
Three patients died due to multiorgan failure. We identi-
fied 6 disease-associated missense mutations that affect
evolutionarily conserved amino acid residues. These var-
iants are either novel or found at an allele frequency less
than 0.0001 in public databases, consistent with recessive
disease inheritance. Two apparently unrelated patients
shared the same genotype. Recently, loss-of-function
mutations in the same gene were reported in patients
with a syndrome termed SIFD (sideroblastic anemia,
immunodeficiency, periodic fevers and developmental
delay). Four mutations from our study have not been
reported in patients with SIFD. Knockdown of the
zebrafish TRNT1 homologue caused abnormalities
resembling the human phenotype. Preliminary results of
next-generation tRNA sequencing showed a significant
down-regulation of mature tRNAs in patient’s fibro-
blasts compared to healthy control. RNA-sequencing of
patients’ whole blood showed an up-regulation in the
expression of neutrophil-related genes. Consistent with
these data, analysis of lesional biopsies from one
patient’s colon showed cryptitis with neutrophilic infil-
tration. Cytokine profiling of stimulated patients’ leuko-
cytes and serum samples suggest that the inflammatory
phenotype is likely driven by IL-6 and interferon. Treat-
ment with TNF inhibitors has shown promising results
in attenuating the systemic inflammation and stabilizing
the anemia in 3 patients who experienced recurrent
fevers and required transfusions.
Conclusions
Hypomorphic mutations in TRNT1 are associated with a
new autoinflammatory disease manifesting a variable
phenotype of fevers, congenital sideroblastic anemia,
immunodeficiency, and developmental delay. Study of
the underlying disease mechanisms might lead to the
discovery of a new pathway regulating immune function
and inflammation.
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